Genes2Me’s oncology point-of-care assay portfolio supports rapid molecular detection of key cancer-associated genetic markers used in diagnosis, prognosis, and therapy monitoring. The range includes assays for clinically significant targets such as BCR-ABL, JAK2, FLT3, PML-RARA, and HLA-B27, enabling accurate detection across hematological malignancies and related conditions. Designed for efficiency and reliability, these assays help simplify complex oncological testing workflows in decentralized and near-patient settings.
Point-of-Care PCR Kits are compatible with a wide range of clinical specimens, enabling comprehensive diagnostic testing from diverse sample types.
Whole Blood
Saliva
Nasopharyngeal Swabs
Plasma/Serum
Urine
Fresh Tissue
Other Body Fluids
Download useful documents and technical information for Point-of-Care PCR Kits.
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.
